[HTML][HTML] EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
J Hou, H Li, S Ma, Z He, S Yang, L Hao, H Zhou… - Biomarker …, 2022 - Springer
Platinum-based chemotherapy was previously the first-choice treatment for lung cancer. The
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives.
J Hou, H Li, S Ma, Z He, S Yang, L Hao, H Zhou… - Biomarker …, 2022 - europepmc.org
Platinum-based chemotherapy was previously the first-choice treatment for lung cancer. The
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
[HTML][HTML] EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
J Hou, H Li, S Ma, Z He, S Yang, L Hao… - Biomarker …, 2022 - ncbi.nlm.nih.gov
Platinum-based chemotherapy was previously the first-choice treatment for lung cancer. The
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
J Hou, H Li, S Ma, Z He, S Yang, L Hao… - Biomarker …, 2022 - pubmed.ncbi.nlm.nih.gov
Platinum-based chemotherapy was previously the first-choice treatment for lung cancer. The
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
J Hou, H Li, S Ma, Z He, Y Sen, L Hao… - Biomarker …, 2022 - search.proquest.com
Platinum-based chemotherapy was previously the first-choice treatment for lung cancer. The
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives.
J Hou, H Li, S Ma, Z He, S Yang, L Hao… - Biomarker …, 2022 - search.ebscohost.com
Platinum-based chemotherapy was previously the first-choice treatment for lung cancer. The
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
[HTML][HTML] EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
J Hou, H Li, S Ma, Z He, S Yang… - Biomarker …, 2022 - biomarkerres.biomedcentral.com
Platinum-based chemotherapy was previously the first-choice treatment for lung cancer. The
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
[PDF][PDF] EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
J Hou, H Li, S Ma, Z He, S Yang, L Hao, H Zhou… - 2022 - biomarkerres.biomedcentral.com
Platinum-based chemotherapy was previously the first-choice treatment for lung cancer. The
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives.
J Hou, H Li, S Ma, Z He, S Yang, L Hao, H Zhou… - Biomarker …, 2022 - europepmc.org
Platinum-based chemotherapy was previously the first-choice treatment for lung cancer. The
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …
discovery of epidermal growth factor receptor (EGFR) gene mutations and the development …